Revolutionising cancer diagnostics
A step change in the detection, diagnosis and monitoring of disease.
Biofidelity’s unique technology enables fast, simple and ultra-sensitive detection of genetic panels from both tissue and liquid biopsies using existing laboratory instrumentation.
Identi-Lung
Comprehensive coverage of NCCN guideline recommended markers for NSCLC
- 115 markers across 10 genes
- 0.1% allele-fraction sensitivity in a simple workflow
- Simultaneous DNA & RNA analysis on one instrument
Latest News
11 February 2021
Biofidelity opens new headquarters as part of significant expansion and drive to commercialization
01 December 2020
01 December 2020